DVB

This is the old debate: should I invest in an enabler or beneficiary? Meaning: Does this company aid the AI buildout, or just use AI to improve its service? Examples of enablers are semis, memory, neoclouds, photonics. The picks and shovels. Beneficiaries are fintech, SaaS, healthcare, etc.. Right now, enablers are gaining all of the value. $SIVE is up 1000% in 2 moths. $MU is up 200% in 2 months. Yet the beneficiaries are losing their value. $ZETA is down 50% in 2 years. $DUOL is down 80% in 1 year. What's happening to the beneficiaries? They're going down because investors think AI will replace their business. Every investor is screaming "SaaS is dead." But that's really only for the vibe coded SaaS companies, not the incumbents. It seems to be the case that switching costs are too high and this gives them time to add all the features that your favorite startup flexes on Twitter. That is why so many of these companies in the beneficiary niche are undervalued. Also, let's not forget, with AI, it actually allows these companies to produce more with less cost -> actually benefiting them overall. Not a bad place to be buying these names for the long-term imo: $WDAY (Workday inc) $NOW (ServiceNow inc) $SAP (Sap IE) $CRM (Salesforce inc) $TEAM (Atlassian Corp) $DUOL (Duolingo inc) $ZETA (Zeta Global) $INTU (Intuit inc) $VEEV (Veeva Systems inc) And more. Also, I'm not saying enablers will go down. I'm invested in a lot of them. I'm just saying the hate on beneficiaries is not deserved. Yes, some will die, but most of them with moats, will continue to push forward. And actually, produce more efficiently in the future, all while it is at a discounted price today. This is just my 2c. - Con